Emord Extends Effort To Liberalize QHCs With Selenium, Antioxidant Petitions
This article was originally published in The Tan Sheet
Executive Summary
Attorney Jonathan Emord continues his effort to force FDA to allow more expansive qualified health claims for nutritional supplements with two petitions relating to the capability of selenium and antioxidant vitamins to reduce the risk of site-specific cancers
You may also be interested in...
FDA Looms Large As Bayer Surrenders One A Day Selenium Prostate Claims
Bayer seems to be heeding FDA's message that the administration will not tolerate playing fast and loose with health claims
Soy, Selenium Claims Should Perhaps Be Expanded, Not Weakened – CRN
The Council for Responsible Nutrition recommends FDA maintain the health claim linking soy protein and reduced heart disease risk and consider adding language to address the "possible contribution" of other soy components
FDA Tackles Observational Studies In Draft Health Claims Guidance
"Scientific conclusions from observational studies cannot be drawn about a relationship between a food component and a disease," FDA concludes in draft guidance for health claim petitioners